Emmes Acquires Institut Dr. Schauerte, Entering Real World Evidence Market

Emmes Acquires Institut Dr. Schauerte, Entering Real World Evidence Market
Third Add-on Acquisition Under Behrman’s Ownership Expands European Presence in Germany; Adds New Electronic Data Capture Tool to Enhance Real World Evidence Research
ROCKVILLE, Emmes (the “Company”), a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation and a portfolio company of Behrman Capital, today announced that it has acquired Institut Dr. Schauerte (IDS), a CRO headquartered in Munich, Germany. Founded in 1990, IDS is a full-service, technology-oriented CRO that specializes in late-phase, non-interventional, and post-market clinical follow-up studies. It has …

Read the source article at biospace.com
2021-12-21 02:00:00